RARE PHARMA-GRADE BARITE AND IODINE IN NORTH AMERICA
- Voyageur Minerals Ltd., VM: TSX-V Is developing near term cash flow on barite projects in BC, Canada and is actively exploring and developing Iodine & lithium brine projects in Utah USA.
- VM business plan is to immediately develop its advanced stage industrial grade barite deposit, Frances Creek, and create cash flow. Voyageur is developing barium contrast suspension products for the pharmaceutical industry.
- VM’s industrial grade barite is naturally occurring with grades as high as 99.26% BaSO4 in-situ, which is very rare.
- Voyageur has strategically partnered with a Canadian pharmaceutical company, Chief Medical Supply Ltd. who specializes in contrast formulation, contrast manufacturing. The structure of the JV is as follows: Voyageur provides USP grade barium sulfate from the Frances Creek property and Chief provides formulation, testing, quality control and GMP pharmaceutical manufacturing. The initial manufacturing and bottling will be carried out at the Calgary plant with capabilities to expand contrast development and manufacturing at the Mississauga plant. Each party receives 50% of the revenue less the cost of regulatory and marketing of the barium contrast within the JV. None of the assets (bottling plant or mine) reside within the JV.
- High grade barite market in Canada & the USA 100% reliant upon imports from China
- High grade barite market in Canada & the USA 100% reliant upon imports from China
COMPANY NEWS
December 18, 2019
Voyageur Pharmaceuticals, Upgrades Frances Creek Barite to 98% BaSO4 with First Stage Gravity Separation
[fusion_builder_container hundred_percent="no" hundred_percent_height="no" hundred_percent_height_scroll="no" hundred_percent_height_center_content="yes" equal_height_columns="no" menu_anchor="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" status="published" publish_date="" class="" id="" border_size="" border_color="" border_style="solid" margin_top="" margin_bottom="" padding_top="" padding_right="" padding_bottom=""…
FULL ARTICLE »
December 11, 2019
Change of Name to Voyageur Pharmaceuticals Ltd., Frontier and Stock House Retained for Marketing & IR, Shares for Debt Transaction, Extension of Warrants, Resignation of Director
[fusion_builder_container hundred_percent="no" hundred_percent_height="no" hundred_percent_height_scroll="no" hundred_percent_height_center_content="yes" equal_height_columns="no" menu_anchor="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" status="published" publish_date="" class="" id="" background_color="" background_image="" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" enable_mobile="no"…
FULL ARTICLE »
November 6, 2019
Voyageur Minerals’ Joint Venture Company, ImagingX Pharmaceuticals, Submits Third Barium Contrast Product to Health Canada for Registration
Voyageur Minerals’ Joint Venture Company, ImagingX Pharmaceuticals, Submits Third Barium Contrast Product to Health Canada for Registration